Cargando…
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp(™)
Without an approved vaccine or treatment, Ebola outbreak management has been limited to palliative care and barrier methods to prevent transmission. These approaches, however, have yet to end the 2014 outbreak of Ebola after its prolonged presence in West Africa. Here we show that a combination of m...
Autores principales: | Qiu, Xiangguo, Wong, Gary, Audet, Jonathan, Bello, Alexander, Fernando, Lisa, Alimonti, Judie B., Fausther-Bovendo, Hugues, Wei, Haiyan, Aviles, Jenna, Hiatt, Ernie, Johnson, Ashley, Morton, Josh, Swope, Kelsi, Bohorov, Ognian, Bohorova, Natasha, Goodman, Charles, Kim, Do, Pauly, Michael H., Velasco, Jesus, Pettitt, James, Olinger, Gene G., Whaley, Kevin, Xu, Bianli, Strong, James E., Zeitlin, Larry, Kobinger, Gary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214273/ https://www.ncbi.nlm.nih.gov/pubmed/25171469 http://dx.doi.org/10.1038/nature13777 |
Ejemplares similares
-
Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
por: Wong, Gary, et al.
Publicado: (2014) -
Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
por: Castilho, Alexandra, et al.
Publicado: (2011) -
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013) -
ZMapp: The Ethics of Decision Making
por: Oldstone, Michael B.A., et al.
Publicado: (2017) -
Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model
por: Zeitlin, Larry, et al.
Publicado: (2013)